|
|
H2020/CTD7980/16504
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9776/21543
|
DOLUTEGRAVIR TABLETS 50 MG
|
DOLUTEGRAVIR (AS SODIUM)
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2025/CTD12306/26376
|
ABACAVIR (AS SULFATE), DOLUTEGRAVIR (AS SODIUM) AND LAMIVUDINE 60 MG/ 5 MG/ 30 MG DISPERSIBLE TABLETS
|
ABACAVIR SULFATE USP DOLUTEGRAVIR SODIUM LAMIVUDINE USP
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9938/22681
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/ 300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|